INTRODUCTION
The ability to understand and counteract weightlessness-induced bone loss will be critical for crew health and safety during and after space station or exploration missions lasting months or years, respectively. Until its deorbit in 2001 , the Mir Space Station provided a valuable platform for long-duration space missions and life sciences research. Long-duration flights are critical for studying bone loss, as the 2-to 3-week Space Shuttle flights are not long enough to detect changes in bone mass. This review will describe human spaceflight data, focusing on biochemical surrogates of bone and calcium metabolism. This subject has been reviewed previously. [1] [2] [3] [4] [5] [6] [7] [8] [9] BONE L OSS Bone mineral is lost during spaceflight because weightlessness unloads the skeleton. [10] [11] [12] [13] [14] [15] [16] [17] This has been known for decades, but determining predictive factors or showing changes that are consistent from subject to subject has proved difficult.
When changes in bone density are caused by unloading, the changes in different skeletal regions do not necessarily correlate with the change in total body calcium or overall calcium loss.
Oganov et al. 16 found mineral losses averaging 2.8, 8.2, 5.0, and 6.2% in the tibia, greater trochanter, _femoral neck, and lumbar v~rtebrae, respe?tiv~y, of 7 exercis~g cosmo~auts v:~o stayed on Mir for 4 to 6 months. These 7 crewmembers had no change in total body calcium.
Both spaceflight and ground-based analog studies have shown that the loss of calcium from bones varies among sites within a subject, and that the nature and degree ofloss over time varies between sUbjects. 12, 14, [17] [18] [19] [20] Virtually every astronaut on missions longer than 30 days has lost bone in some region.
The constraints and difficulties of spaceflight research have prevented studies to date from finding any explanation for individual differences .
Whether factors such as exercise (type, frequency, technique, etc.), diet, and environment playa role in this variability has yet to be determined. Such factors may be critical in finding countermeasures for bone loss of spaceflight, or conversely, they may influence the effectiveness of a countermeasure once it has been defmed. For instance, in the event that an exercise profile is defined that preserves bone during weightlessness, and a crewrnember is not consuming enough calcium, then the countermeasure may appear to have failed. Given the small number of crewmembers available for study, this might prove to be a significant hindrance to resolving the problem of bone loss.
CALCIUM BALANCE AND CALCIUM METABOLISM
Negative calcium balance was observed during Skylab ll ,2 1-23 and Mir4 mISSIOns.
Increased urinary and fecal calcium excretion accounted for most of the deficit. li ,14,21-23,2S-27
Increased calcium excretion is a major contributor to the increased risk of renal stone formation d~~_ 3?d after spa~ep~g~. [25] [26] [27] Recent studies with calcium 24 and strontium 28 tracers have shown that the calcium absorption of crewrnembers decreased aboard the Mir space station. The calcium tracer studies included mathematical modeling of the calcium kinetics, which estimated a net bone calcium loss 3 ----of about 250 mg/d. 24 This fits very closely with the Skylab calcium balance data, which showed whole-body calcium losses of200 to 300 mg/d. l While early hypotheses suggested that space travelers' serum concentrations of total and ionized calcium would increase, only very small changes have been noted, and those have had only statistical rather than clinical significance. 24 ,29 Thus, despite the bone loss and hypercalciuria associated with spaceflight, the body's regulation of circulating calcium levels remains intact.
BONE METAB OLISM AND BONE MARKERS
As a living tissue, bone is constantly subject to remodeling through the processes of bone formation and bone resorption. The activity of these processes may be determined by a number of methods, ranging from extremely invasive (bone biopsy) to noninvasive (markers found in urine). The battery of biochemical markers available has evolved over the past 4 decades of humans flying in space. Although more sensitive and specific markers have recently become available, it is reassuring to find that the results of studies showing the effects of spaceflight on bone metabolism are very consistent, essentially regardless of technique.
Bone formation is generally unchanged or decreased during spaceflight. Typically, blood which are bone-specific alkaline phosphatase (B SAP) and osteocalcin. Studies from a few astronauts and cosmonauts on Mir have yielded mixed results, but again, the general finding was that these markers were unchanged or decreased compared to their preflight serum concentrations. 24 ,30,31 ,32 Kinetic studies with calcium tracers yielded similar results for bone formation (i.e., it decreased in one crewmember and was unchanged in the other twO) ?4 In all of these studies, unfortunately, the number of subjects was very small. The 1990s brought the ability to measure collagen crosslinks, a family of compounds that appear in the urine as a result of collagen degradation associated with bone resorption. Several crosslink fragments can be measured by high-performance liquid chromatography, and many by C?gun~!9}.~lly avai!a~le enzyrpe-linked irnrn~osor~~nt a~~ays. Frag:rp.e:gts <2fjpterest in~L~~ pyridinoline, deoxypyridinoline, N-telopeptide, and C-telopeptide. In general, all provide similar results. The advantages of using crosslinks include the fact that these compounds are formed only in mature collagen, and thus their release reflects breakdown of mature collagen; the 5 1 -"~--" fragments are not absorbed from the gut, and thus dietary consmnption does not confound results; and these compounds are extremely stable in fro zen urine samples for a long period.
Data from spaceflight studies very consistently show increased levels of markers of bone resorption. 24 ,30,3 1, 3 5,36 Calcium tracer kinetic data also indicated that bone resorption increased about 50% during flight. 24 Because of the increasing use of collagen crosslinks as markers, a few comments are warranted about common perceptions and misconceptions. Critics of using collagen crosslinks often point out that they vary considerably from day to day and from subject to subject, and this criticism is well founded. However, the day-to-day variability may be minimized by extending the sample collection period, an action more easily accomplished in research than in clinical settings. With regard to the subject-to-subject variability, although this is indeed considerable, the response to intervention (e.g., spaceflight, bed rest, or exercise) is highly consistent between subj ects. For example, although the amount of a collagen crosslink excreted in 24 hours can easily vary 5-to la-fold between 2 subjects, if those same 2 subjects go into space, they will have the same magnitude of response compared to their preflight level.
Another common issue is that of normalizing crosslink excretion to creatinine excretion.
Whereas in a clinical setting the collection of individual urine voids may make this necessary, in
research it should be avoided wherever possible. This is especially, and perhaps obviously, true One clear limitation of using these biochemical markers is that they reflect changes in the entire skeletal system, and regional differences may be missed or masked. Because of this, whenever possible the bone markers should be determined in conjunction with other tests (bone 6 I~--' ' , -~--" -_.
---" . ,. , --_. -~density measurements, for example), to ensure that multiple perspectives are considered.
However, the changes in spaceflight are clear enough to alleviate concerns about this potential problem.
ENDOCRINE EFFECTS
In an attempt to define the mechanism of weightlessness-induced bone loss, many studies have focused on the endocrine regulation of bone and calcium metabolism. It is estimated, on the basis of limited available data, that recovery of the lost bone will take about 2 to 3 times the length of the mission. 24 While more data clearly are required to validate tllls hypothesis, it has significant implications as mission durations increase. For planetary missions, the ability of a terrestrial partial g force (such as Mars' 0.38 g)
to reduce bone loss, or even allow recovery to begin, is unknown. While no data exist on responses to partial g , the general consensus among investigators is that forces less than 0.5 g (for example, the Martian 0.38 g) are likely to be of little value to bone. Dietary sodium during spaceflight is also a subj ect of concern, as it is known to affect calcium homeostasis. 4 
DIETARY INFLVENCE

COUNTERMEASURE POTENTIAL
The ability of many countermeasures to ameliorate spaceflight-induced bone loss has been tested. However, the countermeasured tested to date, including exercise, increased calcium and/or phosphate intake, vitamin D supplementation, exposure to ultraviolet light, and administration of early-generation bisphosphonates, have proved ineffective during spaceflight or bed rest. 5 ,46-49 Whether resistive exercise paradigms, newer anti-resorptive therapies, or other therapies involving bone-regulating proteins will prevent or reduce bone loss is yet to be determined. Ensuring adequate di~taryint~ke, Qri,n sQme c,!~es epsurillg adequate syntllel>is., of calcil!ll, vitamin D, vitamin K, and other bone-related nutrients will be necessary, but does not appear to be sufficient to solve the problem of bone loss. Other factors that may also contribute to the degree of calcium loss are age, gender, fitness , genetics, and dietary history. The 9 importance of these in preventing (or hastening) bone loss has yet to be determined.
SUMMARY
Spaceflight-induced bone loss poses significant health risks for astronauts, both acutely and chronically. Future research is required to better understand the nature ofthis bone loss, to define the time course of its effects, and to develop means to counteract it. Successful resolution of these tasks will increase crew safety during spaceflight, will enable human exploration missions, and may provi?e insight into the treatment of diseases on Earth. 
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